Browse the corpus

REFERENCES Amalfitano A, Bengur AR, and Morse RP, “Recombinant Human Acid Alpha-Glucosidase Enzyme Therapy for Infantile Glycogen Disease Type II: Results of a Phase I/II Clinical Trial,” Genet Med , 2001, 3(2):132-8. [PubMed 11286229 ] de Vries JM, Brugma JD, Ozkan L, et al, "First Experience With Enzyme Replacement Therapy During Pregnancy and Lactation in Pompe Disease," Mol Genet Metab , 2011, 104(4):552-5. [PubMed 21967859 ] Klinge L, Straub V, Neudorf U, et al, “Enzyme Replacement Therapy in Classical Infantile Pompe Disease: Results of a Ten-Month Follow-up Study,” Neuropediatrics , 2005, 36(1):6-11. [PubMed 15776317 ] Klinge L, Straub V, Neudorf U, et al, “Safety and Efficacy of Recombinant Acid Alpha-Glucosidase (rhGAA) in Patients With Classical Infantile Pompe Disease: Results of a Phase II Clinical Trial,” Neuromuscular Disorders , 2005, 15(1):24-31. [PubMed 15639117 ] van der Ploeg AT, Clemens PR, Corzo D, et al, “A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe’s Disease, N Engl J Med , 2010, 362(15):1396-406. [PubMed 20393176 ] Topic 9280 Version 34.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1004-125.39.66.146-C1CFDD43C6-S473950.14]